Dr Reddy's Mexico Facility Undergoes USFDA Records Assessment

Dr. Reddy's Laboratories announced that its API manufacturing facility in Mexico, Industrias Químicas Falcón de México, S.A. de C.V., recently underwent a records assessment by the United States Food and Drug Administration (USFDA). The assessment, conducted between July 17, 2026, and September 8, 2026, concluded with the issuance of a Form FDA 2953, which included two observations. Dr. Reddy's stated that it will respond to these observations within the stipulated timeline. This disclosure is made in accordance with SEBI (LODR) Regulations, 2015.